Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Arno Therapeutics Price Performance
Arno Therapeutics Company Profile
Arno Therapeutics, Inc (OTCMKTS:ARNI) is a development‐stage biopharmaceutical company focused on the research and development of targeted therapeutics for oncology indications and rare genetic disorders. The company’s mission is to apply innovative biologic and protein engineering platforms to create therapies that address significant unmet medical needs in cancer and inherited metabolic conditions.
Arno’s pipeline centers on antibody‐based drug conjugates and recombinant fusion proteins designed to selectively target tumor cells or restore deficient enzyme activity in rare diseases.
See Also
- Five stocks we like better than Arno Therapeutics
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
